European VCs ‘actively seeking new healthcare investments’

The disruption caused by the coronavirus crisis hasn’t dampened the enthusiasm of European venture capitalists to make funding available to healthcare companies, says a ne

ECJ backs UK regulator’s ‘pay-for-delay’ fine levied on GSK

Shaping the patient-centric evolution of HTA in Europe

Patient engagement is one of the most important drivers for improving healthcare delivery but, as Krystallia Pantiri explains, approaches by European health technology assessment (HTA) bodi

Transforming oncology with a pan-European approach to data s...

Between genomic data, electronic health records and digital health tools, we have all the information we need to transform the fortunes of people living with cancer – but how do we ensure i

Alexion’s biosimilar-blocking EU patent play for Soliris fai...

UK pharma patents up 20%, new report finds

The pharma industry saw double-digit growth in patent filings for the second year in a row in 2018, with applications from the UK up by a fifth, according to the latest